Transient protection against streptozotocin-induced diabetes has been observed possibly due to many GLUT2-mediated effects, including drug access to pancreatic ß cells [20], but not to accelerated urinary glucose loss or larger stores of pancreatic insulin. The gene discussed is INS; the disease is diabetes mellitus.